FDA Adverse Event Injury Summary report: N

ORTHADAPT BIOIMPLANT

MDR report key: 1559628 · Received December 11, 2009

Report

Report Number
3005147058-2009-00144
Event Type
Injury
Date Received
December 11, 2009
Date of Event
December 6, 2007
Report Date
December 10, 2009
Manufacturer
PEGASUS BIOLOGICS, INC.
Product Code
FTM
PMA / PMN Number
K071065
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
GA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE PHYSICIAN PERFORMED COBLATION THERAPY WITH TOPAZ ON THE POSTERIOR TIBIALIS TENDON TO DEBRIDE A NONVIABLE/ THICKENED SECTION. THE TENDON RUPTURE WAS RE-APPROXIMATED WITH 3-0 VICRYL SUTURE FOLLOWED BY ORTHADAPT AUGMENTATION OVER THE TENDON SHEATH. THE CASE ASSESSMENT, BASED ON THE PROVIDED INFORMATION, COULD NOT DETERMINE THE SPECIFIC CAUSE OF THE EVENT; HOWEVER, THE COMBINATION OF POOR NATIVE TISSUE COBLATED WITH TOPAZ, METHOD OF BIOIMPLANT FIXATION AND INFECTION COULD NOT BE RULED OUT AS POSSIBLE CONTRIBUTORS TO THE EVENT. PHYSICIAN INDICATED THAT WHEN THE BIOIMPLANT WAS REMOVED, THE NATIVE TISSUE WAS HEALED. THE MANUFACTURER OF THE DEVICE AT THE TIME WAS PEGASUS BIOLOGICS, INC.

Description of Event or Problem · 1

PATIENT DEVELOPED EDEMA ON THE LEFT ANKLE APPROXIMATELY THREE MONTHS POST POSTERIOR TIBIALIS TENDON REPAIR WITH TOPAZ DEBRIDEMENT AND TENDON SHEATH AUGMENTATION WITH ORTHADAPT. TWO WEEKS LATER, 15 CC OF FLUID WAS ASPIRATED. ONE WEEK LATER, EXPLORATORY SURGERY REVEALED THE NATIVE TISSUE WAS HEALED AND SUBSEQUENTLY, THE BIOIMPLANT WAS REMOVED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ORTHADAPT BIOIMPLANT SURGICAL MESH FTM PEGASUS BIOLOGICS, INC. UNK UNK

Patients

Seq Age Sex Outcome Treatment
1 61 YR Hospitalization LEFT| TOPAZ - DEBRIDEMENT OF THE LEFT POSTERIOR TIBIALIS| TENOSYNOVITIS OF THE POSTERIOR TIBIALIS TENDON| TENDON